Tvardi Therapeutics, Inc. Common Stock (NASDAQ: TVRD) last traded at $1.86, up 1.64% on the session. The quote above updates while this page is open; the figures below are drawn from Tvardi Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Tvardi Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TVRD. Its market capitalisation is $24.81 million.
Valuation measures for Tvardi Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $24.81M |
|---|---|
| Enterprise value | $18.18M |
| Price / sales | 3.28 |
| Price / book | 2.96 |
| Beta | 0.42 |
Trailing-twelve-month figures tagged in Tvardi Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $7.57M |
|---|---|
| Net income (TTM) | -$26.06M |
| Operating margin | -359.33% |
| Return on equity | -310.94% |
| Cash | $15.77M |
Range and volume for TVRD over the past 52 weeks.
| 52-week high | $43.65 |
|---|---|
| 52-week low | $1.50 |
| Volume | 166.8K |
| Average volume | 2.33M |
| Previous close | $1.83 |
Dividend history for Tvardi Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.